Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00995072 · ClinicalTrials.gov registry record · NA
Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function
A NA study, sponsored by East Coast Institute for Research.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT00995072: Completed NA study, sponsored by East Coast Institute for Research.
NCT00995072 is a NA study that has completed, run by East Coast Institute for Research. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00995072, a NA study, has completed, sponsored by East Coast Institute for Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
Beta-blockers (BB) are an important treatment for high blood pressure and heart disease. However beta-blockers can cause sexual dysfunction (SD) and this common side effect limits successful use of this class of medications. Sexual side effects often result in drug discontinuation, compromising therapy goals. The investigators are conducting the study to determine if nebivolol, a newer beta blocker that is selective for receptors in the heart and causes vasodilation in the body causes fewer sexual side effects, or even improves sexual function, compared with metoprolol succinate.
Primary Outcome
This scale is a self-reported instrument used to detect female sexual function. The scale ranges from 2 to 36. The higher score indicates higher sexual function.
Interventions
- DRUG nebivolol and metoprolol succinate
- DRUG metoprolol succinate and nebivolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2009-10 |
| Est. Completion | 2013-04 |
| Phase | NA |
What the finished NCT00995072 record still lists
NCT00995072 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which nebivolol and metoprolol succinate is the first listed.
NCT00995072 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00995072 about?
NCT00995072 is a clinical study titled "Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function". Beta-blockers (BB) are an important treatment for high blood pressure and heart disease. However beta-blockers can cause sexual dysfunction (SD) and this common side effect limits successful use of this class of medications. Sexual side effects often result in drug discontinuation, compromising ther...
What is the current status of trial NCT00995072?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2009-10. Estimated completion is 2013-04.
What interventions are being tested in trial NCT00995072?
The interventions under investigation include: nebivolol and metoprolol succinate (DRUG), metoprolol succinate and nebivolol (DRUG).
Who is sponsoring clinical trial NCT00995072?
This trial is sponsored by East Coast Institute for Research, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00995072's enrollment target sits among peer trials
29 1702nd of 2000 higher than 297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia